Ambrilia BioPharma Inc. : Kantasolututkimus, tutkimus, immuunikato...

Select all

Kantasolututkimus

Tutkimus, immuunikato (AIDS)

Tutkimus, Alzheimerin tauti

Tutkimus, Huntingtonin tauti

Tutkimus, kystinen fibroosi (CF)

Etusivu

Kuvaus

Ambrilia Biopharma Inc. (TSX:AMB) is a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases. Ambrilia.s broad pipeline includes proprietary mid to early-stage products and two specialty generics.

Lue lisää »

Timeline

Visit our website @ {{website}}

Our new location address:

AMBRILIA BIOPHARMA INC.

Seeing is believing!

Etusivu

Kuvaus

Timeline

{{companyName}} {{title}}

{{companyName}} {{title}}

Visit our website @ {{website}}

{{companyName}} {{title}}

{{street}}, {{city}}, {{state}}, {{postalCode}}, {{country}}

{{companyName}} {{title}}

^{{symbol}}{{price}}^{{currency}}

{{name}}

{{companyName}} {{title}}

{{name}}

AMBRILIA BIOPHARMA INC.

Seeing is believing!

Etusivu

Kuvaus

Timeline

{{companyName}} {{title}}

{{companyName}} {{title}}

Visit our website @ {{website}}

{{companyName}} {{title}}

{{street}}, {{city}}, {{state}}, {{postalCode}}, {{country}}

{{companyName}} {{title}}

{{symbol}}{{price}}{{currency}}

{{name}}

{{companyName}} {{title}}

{{name}}

^{{symbol}}{{price}}^{{currency}}